397 related articles for article (PubMed ID: 22934129)
1. Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain.
Rogelj B; Easton LE; Bogu GK; Stanton LW; Rot G; Curk T; Zupan B; Sugimoto Y; Modic M; Haberman N; Tollervey J; Fujii R; Takumi T; Shaw CE; Ule J
Sci Rep; 2012; 2():603. PubMed ID: 22934129
[TBL] [Abstract][Full Text] [Related]
2. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs.
Lagier-Tourenne C; Polymenidou M; Hutt KR; Vu AQ; Baughn M; Huelga SC; Clutario KM; Ling SC; Liang TY; Mazur C; Wancewicz E; Kim AS; Watt A; Freier S; Hicks GG; Donohue JP; Shiue L; Bennett CF; Ravits J; Cleveland DW; Yeo GW
Nat Neurosci; 2012 Nov; 15(11):1488-97. PubMed ID: 23023293
[TBL] [Abstract][Full Text] [Related]
3. From transcriptomic to protein level changes in TDP-43 and FUS loss-of-function cell models.
Colombrita C; Onesto E; Buratti E; de la Grange P; Gumina V; Baralle FE; Silani V; Ratti A
Biochim Biophys Acta; 2015 Dec; 1849(12):1398-410. PubMed ID: 26514432
[TBL] [Abstract][Full Text] [Related]
4. Different recognition modes of G-quadruplex RNA between two ALS/FTLD-linked proteins TDP-43 and FUS.
Ishiguro A; Katayama A; Ishihama A
FEBS Lett; 2021 Feb; 595(3):310-323. PubMed ID: 33269497
[TBL] [Abstract][Full Text] [Related]
5. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
Baloh RH
Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
[TBL] [Abstract][Full Text] [Related]
6. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS.
Ito D; Suzuki N
Neurology; 2011 Oct; 77(17):1636-43. PubMed ID: 21956718
[TBL] [Abstract][Full Text] [Related]
7. TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells.
Colombrita C; Onesto E; Megiorni F; Pizzuti A; Baralle FE; Buratti E; Silani V; Ratti A
J Biol Chem; 2012 May; 287(19):15635-47. PubMed ID: 22427648
[TBL] [Abstract][Full Text] [Related]
8. Aberrant interaction between FUS and SFPQ in neurons in a wide range of FTLD spectrum diseases.
Ishigaki S; Riku Y; Fujioka Y; Endo K; Iwade N; Kawai K; Ishibashi M; Yokoi S; Katsuno M; Watanabe H; Mori K; Akagi A; Yokota O; Terada S; Kawakami I; Suzuki N; Warita H; Aoki M; Yoshida M; Sobue G
Brain; 2020 Aug; 143(8):2398-2405. PubMed ID: 32770214
[TBL] [Abstract][Full Text] [Related]
9. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).
Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C
J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD).
Lourenco GF; Janitz M; Huang Y; Halliday GM
Neurobiol Dis; 2015 Oct; 82():445-454. PubMed ID: 26220395
[TBL] [Abstract][Full Text] [Related]
11. Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses.
Kapeli K; Pratt GA; Vu AQ; Hutt KR; Martinez FJ; Sundararaman B; Batra R; Freese P; Lambert NJ; Huelga SC; Chun SJ; Liang TY; Chang J; Donohue JP; Shiue L; Zhang J; Zhu H; Cambi F; Kasarskis E; Hoon S; Ares M; Burge CB; Ravits J; Rigo F; Yeo GW
Nat Commun; 2016 Jul; 7():12143. PubMed ID: 27378374
[TBL] [Abstract][Full Text] [Related]
12. TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration.
Fiesel FC; Kahle PJ
FEBS J; 2011 Oct; 278(19):3550-68. PubMed ID: 21777389
[TBL] [Abstract][Full Text] [Related]
13. Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations.
Finelli MJ; Liu KX; Wu Y; Oliver PL; Davies KE
Hum Mol Genet; 2015 Jun; 24(12):3529-44. PubMed ID: 25792726
[TBL] [Abstract][Full Text] [Related]
14. Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration.
Zhao B; Cowan CM; Coutts JA; Christy DD; Saraph A; Hsueh SCC; Plotkin SS; Mackenzie IR; Kaplan JM; Cashman NR
Acta Neuropathol Commun; 2023 Dec; 11(1):200. PubMed ID: 38111057
[TBL] [Abstract][Full Text] [Related]
15. ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation.
Zhou Y; Liu S; Liu G; Oztürk A; Hicks GG
PLoS Genet; 2013 Oct; 9(10):e1003895. PubMed ID: 24204307
[TBL] [Abstract][Full Text] [Related]
16. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.
Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR
Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875
[TBL] [Abstract][Full Text] [Related]
17. FUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD.
Orozco D; Edbauer D
J Mol Med (Berl); 2013 Dec; 91(12):1343-54. PubMed ID: 23974990
[TBL] [Abstract][Full Text] [Related]
18. FUS interacts with nuclear matrix-associated protein SAFB1 as well as Matrin3 to regulate splicing and ligand-mediated transcription.
Yamaguchi A; Takanashi K
Sci Rep; 2016 Oct; 6():35195. PubMed ID: 27731383
[TBL] [Abstract][Full Text] [Related]
19. Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions.
Ishigaki S; Masuda A; Fujioka Y; Iguchi Y; Katsuno M; Shibata A; Urano F; Sobue G; Ohno K
Sci Rep; 2012; 2():529. PubMed ID: 22829983
[TBL] [Abstract][Full Text] [Related]
20. Extensive splicing changes in an ALS/FTD transgenic mouse model overexpressing cytoplasmic fused in sarcoma.
Ito D; Taguchi R; Deguchi M; Ogasawara H; Inoue E
Sci Rep; 2020 Mar; 10(1):4857. PubMed ID: 32184412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
